文献速递脑血管病外科神经重症

使用血管内和体表降温系统对重型蛛网膜下腔出血进行目标温度管理:采用历史对照的非随机干预研究

Targeted Temperature Management for Severe Subarachnoid Hemorrhage Using Endovascular and Surface Cooling Systems: A Nonrandomized Interventional Study Using Historical Control.
PubMed 文献 · Neurosurgery · 2022-09-09

该非随机干预研究纳入世界神经外科医师联盟分级V级蛛网膜下腔出血患者,比较引入血管内目标温度管理前后两组各36例的疗效。两组均先体表降温至34°C并急诊动脉瘤修复,研究组复温至36°C后使用血管内降温系统维持36至38°C共7天,对照组使用退热药。研究组发热>38°C发生率、发热持续时间、血管痉挛相关脑梗死发生率较低,6个月良好结局比例较高。

要点

  • 研究组发热>38°C发生13例 vs 对照组26例(P=0.0021)。
  • 研究组血管痉挛相关脑梗死发生率17% vs 对照组42%(P=0.037)。
  • 研究组6个月改良Rankin量表0至1分比例42% vs 对照组17%(P=0.037)。

核心结论

  • 体表降温后使用血管内目标温度管理维持36至38°C在重型蛛网膜下腔出血患者中可行且安全实施。
  • 联合目标温度管理2周与较低的血管痉挛相关脑梗死发生率相关,并可能改善结局。

研究设计与样本

  • 采用历史对照的非随机干预研究,比较引入血管内目标温度管理前后世界神经外科医师联盟分级V级蛛网膜下腔出血患者,两组各36例。
  • 两组均在蛛网膜下腔出血诊断后立即接受34°C目标温度管理(体表降温)及急诊动脉瘤修复。
  • 研究组在约7天后复温至36°C时,使用血管内降温系统维持36至38°C共7天;对照组使用退热药。

主要发现

  • 研究组与对照组在性别、年龄、格拉斯哥昏迷量表评分、改良Fisher计算机断层扫描分级、动脉瘤位置及治疗方法上无差异。
  • 发热>38°C发生率:研究组13例 vs 对照组26例(P=0.0021)。
  • 发热>38°C持续时间:研究组4.1小时 vs 对照组18.8小时(P=0.0021)。
  • 血管痉挛相关脑梗死发生率:研究组17% vs 对照组42%(P=0.037)。
  • 6个月改良Rankin量表0至1分(良好结局)比例:研究组42% vs 对照组17%(P=0.037)。

临床怎么用

  • 原文结论认为,体表降温后使用血管内目标温度管理维持36至38°C在重型蛛网膜下腔出血患者中可行且安全实施。
  • 原文结论认为,联合目标温度管理2周与较低的血管痉挛相关脑梗死发生率相关,并可能改善结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although targeted temperature management (TTM) may mitigate brain injury for severe subarachnoid hemorrhage (SAH), rebound fever correlates with poor outcomes. OBJECTIVE: To study the effect of endovascular TTM after rewarming from initial surface cooling during a high-risk period for delayed cerebral ischemia. METHODS: We studied patients with World Federation of Neurological Surgeons grade V SAH before and after the introduction of endovascular TTM. Both groups (36 patients each) were treated with TTM at 34 °C with conventional surface cooling immediately after SAH diagnosis, together with emergency aneurysm repair. When rewarmed to 36 °C, around 7 days later, the study group underwent TTM at 36 to 38 °C for 7 days with an endovascular cooling system. The control group was treated with antipyretics. RESULTS: Sex, age, Glasgow Coma Scale score, modified Fisher computed tomography classification, aneurysm location, and treatment methods were not different between the study and control groups. Differences were detected in the incidence of fever >38 °C (13 vs 26 patients, P = .0021), duration of fever >38 °C (4.1 vs 18.8 hours, P = .0021), incidence of vasospasm-related cerebral infarction (17% vs 42%, P = .037), and the likelihood of excellent outcomes (0 and 1 on a modified Rankin Scale) at 6 months (42% vs 17%, P = .037). In endovascular TTM, shivering occurred more frequently in patients with better outcomes, requiring aggressive treatment to avoid fever. CONCLUSION: Endovascular TTM at 36 to 38 °C after surface cooling was feasible and safely performed in patients with severe SAH. Combined TTM for 2 weeks was associated with a lower incidence of vasospasm-related infarction and may improve outcomes.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Kobata H, Tucker A, Sarapuddin G, et al. Targeted Temperature Management for Severe Subarachnoid Hemorrhage Using Endovascular and Surface Cooling Systems: A Nonrandomized Interventional Study Using Historical Control. Neurosurgery. 2022. PMID: 36083144. doi:10.1227/neu.0000000000002122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。